Alectinib impressively enters the adjuvant setting for early-stage -rearranged non-small cell lung cancer and outperforms chemotherapy-let's define who benefits the most.
作者信息
Santoni-Rugiu Eric, Sørensen Jens Benn, Urbanska Edyta Maria
机构信息
Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
出版信息
Transl Lung Cancer Res. 2025 Feb 28;14(2):310-313. doi: 10.21037/tlcr-24-961. Epub 2025 Feb 21.
Abstract
摘要
Zotero 插件